1 stories
AI briefings + tags; source links are the ground truth.
About
🇩🇰
Denmark
Politiken
National & Local
Sales of migraine medication drives Lundbeck's revenue growth
Danish pharmaceutical company Lundbeck has increased its revenue by 13% to 24.6 billion kroner in 2025, driven by the success of medications Vyepti and Rexulti, although net profit has not kept pace with sales growth.
Feb 4 • 07:00 UTC